A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol

NCT01421433 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
160
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Farmoquimica S.A.

Collaborators